Antiproliferative activities of Garcinia bracteata extract and its active ingredient, isobractatin, against human tumor cell lines

Archives of Pharmacal Research

Volumn 37, Issue 3, 2014, Pages 412-420

  Shen, Tao ^a   Li, Wei ^b   Wang, Yan Yan ^a   Zhong, Qing Qing ^c   Wang, Shu Qi ^a   Wang, Xiao Ning ^a   Ren, Dong Mei ^a   Lou, Hong Xiang ^a  

^a SHANDONG UNIVERSITY   (China)

^b Binzhou Central Hospital   (China)

^c SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Antitumor; Garcinia bracteata; Guttiferae; Isobractatin; Xanthone

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN E; GARCINIA BRACTEATA EXTRACT; ISOBRACTATIN; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; GARCINIA; GARCINIA BRACTEATA; HUMAN; HUMAN CELL; IC 50; LUNG ADENOCARCINOMA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYTOCHEMISTRY; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR CELL LINE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; ISOLATION AND PURIFICATION; MCF 7 CELL LINE; PHYSIOLOGY; PLANT;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GARCINIA; HUMANS; MCF-7 CELLS; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS;

EID: 84896397457     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0196-1     Document Type: Article

References (54)

1. Acuna, U.M.; N. Jancovski, and E.J. Kennelly. 2009. Polyisoprenylated benzophenones from Clusiaceae: potential drugs and lead compounds. Current Topics in Medicinal Chemistry 9: 1560-1580.
2. Baliga, M.S.; H.P. Bhat, R.J. Pai, R. Boloor, and P.L. Palatty. 2011. The chemistry and medicinal uses of the underutilized Indian fruit tree Garcinia indica Choisy (kokum): A review. Food Research International 44: 1790-1799.
3. Botta, B.; G.D. Monache, F.D. Monache, G.B.M. Bettolo, and F. Menichini. 1986. Vismione-H and prenylated xanthones from Vismia guineensis. Phytochemistry 25: 1217-1219.
4. Brugarolas, J.; R.T. Bronson, and T. Jacks. 1998. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells. Journal of Cell Biology 141: 503-514.
5. Bursch, W.; F. Oberhammer, and R. Schulte-Hermann. 1992. Cell death by apoptosis and its protective role against disease. Trends in Pharmacological Sciences 13: 245-251.
6. Carnero, A. 2002. Targeting the cell cycle for cancer therapy. British Journal of Cancer 87: 129-133.
7. Chantarasriwong, O.; A. Batova, W. Chavasiri, and E.A. Theodorakis. 2010. Chemistry and biology of the caged Garcinia xanthones. Chemistry A European Journal 16: 9944-9962.
8. Coultas, L.; and A. Strasser. 2003. The role of the Bcl-2 protein family in cancer. Seminars in Cancer Biology 13: 115-123.
9. Deng, Y.-X.; S.-L. Pan, S.-Y. Zhao, M.-Q. Wu, Z.-Q. Sun, X.-H. Chen, and Z.-Y. Shao. 2012. Cytotoxic alkoxylated xanthones from the resin of Garcinia hanburyi. Fitoterapia 83: 1548-1552.
10. El-Seedi, H.R.; M.A. El-Barbary, D.M.H. El-Ghorab, L. Bohlin, A.-K. Borg-Karlson, U. Göransson, and R. Verpoorte. 2010. Recent insights into the biosynthesis and biological activities of natural xanthones. Current Medicinal Chemistry 17: 854-901.
11. Fesik, S.W. 2005. Promoting apoptosis as a strategy for cancer drug discovery. Nature Reviews Cancer 5: 876-885.
12. Gao, X.M.; T. Yu, M. Cui, J.X. Pu, X. Du, Q. Han, Q. Hu, T.C. Liu, K.Q. Luo, and H.X. Xu. 2012. Identification and evaluation of apoptotic compounds from Garcinia oligantha. Bioorganic & Medicinal Chemistry Letters 22: 2350-2353.
13. Ghobrial, I.M.; T.E. Witzig, and A.A. Adjei. 2009. Targeting apoptosis pathways in cancer therapy. CA: A Cancer Journal for Clinicians 55: 178-194.
14. Green, D.R.; and J.C. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309-1311.
15. Han, Q.B.; and H.X. Xu. 2009. Caged Garcinia xanthones: development since 1937. Current Medicinal Chemistry 16: 3775-3796.
16. Hemshekhar, M.; K. Sunitha, M.S. Santhosh, S. Devaraja, K. Kemparaju, B.S. Vishwanath, S.R. Niranjana, and K.S. Girish. 2011. An overview on genus Garcinia: phytochemical and therapeutical aspects. Phytochemistry Reviews 10: 325-351.
17. Janssen, A.; and R. Medema. 2011. Mitosis as an anti-cancer target. Oncogene 30: 2799-2809.
18. Kang, K.H.; W.H. Kim, and K.H. Choi. 1999. p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. Experimental Cell Research 253: 403-412.
19. LaBaer, J.; M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, H.S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes & Development 11: 847-862.
20. Li, X.; Li, J.; Norman, K. B. R.; & Peter, F. S.; Guttiferae. (2008) In Flora of China Editorial Committee (Ed). The English edition of flora of China, Vol 13. Beijing: Science Press.
21. Lin, K.-W.; A.M. Huang, S.-C. Yang, J.-R. Weng, T.-C. Hour, Y.-S. Pu, and C.-N. Lin. 2012. Cytotoxic and antioxidant constituents from Garcinia subelliptica. Food Chemistry 135: 851-859.
22. Liu, H.; Y. Liu, A. Xu, C.Y.F. Young, H. Yuan, and H. Lou. 2010a. A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells. Chemico-Biological Interactions 188: 598-606.
23. Liu, X.; T. Yu, X.M. Gao, Y. Zhou, C.F. Qiao, Y. Peng, S.L. Chen, K.Q. Luo, and H.X. Xu. 2010b. Apoptotic effects of polyprenylated benzoylphloroglucinol derivatives from the twigs of Garcinia multiflora. Journal of Natural Products 73: 1355-1359.
24. Madan, B.; I. Singh, A. Kumar, A.K. Prasad, H.G. Raj, V.S. Parmar, and B. Ghosh. 2002. Xanthones as inhibitors of microsomal lipid peroxidation and TNF-alpha induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs). Bioorganic & Medicinal Chemistry 10: 3431-3436.
25. Malumbres, M.; and M. Barbacid. 2009. Cell cycle, CDKs and cancer: a changing paradigm. Nature Reviews Cancer 9: 153-166.
26. Na, Y. 2009. Recent cancer drug development with xanthone structures. Journal of Pharmacy and Pharmacology 61: 707-712.
27. Na, Z.; H.B. Hu, and Q.F. Fan. 2010a. A novel caged-prenylxanthone from Garcinia bracteata. Chinese Chemical Letters 21: 443-445.
28. Na, Z.; H.B. Hu, and Q.F. Fan. 2010b. Three new caged prenylxanthones from Garcinia bracteata. Helvetica Chimica Acta 93: 958-963.
29. Nguyen, H.D.; B.T.D. Trinh, and L.H.D. Nguyen. 2011. Guttiferones Q-S, cytotoxic polyisoprenylated benzophenones from the pericarp of Garcinia cochinchinensis. Phytochemistry Letters 4: 129-133.
30. Niu, S.L.; Z.L. Li, F. Ji, G.Y. Liu, N. Zhao, X.Q. Liu, Y.K. Jing, and H.M. Hua. 2012. Xanthones from the stem bark of Garcinia bracteata with growth inhibitory effects against HL-60 cells. Phytochemistry 77: 280-286.
31. Obolskiy, D.; I. Pischel, N. Siriwatanametanon, and M. Heinrich. 2009. Garcinia mangostana L.: A phytochemical and pharmacological review. Phytotherapy Research 23: 1047-1065.
32. Pedraza-Chaverri, J.; N. Cárdenas-Rodríguez, M. Orozco-Ibarra, and J.M. Pérez-Rojas. 2008. Medicinal properties of mangosteen (Garcinia mangostana). Food and Chemical Toxicology 46: 3227-3239.
33. Reed, J.C. 1997. Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Seminars in Hematology, 9.
34. Saadat, N.; and S.V. Gupta. 2012. Potential role of garcinol as an anticancer agent. Journal of Oncology 2012: 1-8.
35. Sakurai, N.; Y. Yaguchi, and T. Inoue. 1987. Constituents of Myrica rubra.2. Triterpenoids from Myrica rubra. Phytochemistry 26: 217-219.
36. Shen, T.; W. Wan, H. Yuan, F. Kong, H. Guo, P. Fan, and H. Lou. 2007. Secondary metabolites from Commiphora opobalsamum and their antiproliferative effect on human prostate cancer cells. Phytochemistry 68: 1331-1337.
37. Shen, T.; L. Zhang, Y.-Y. Wang, P.-H. Fan, X.-N. Wang, Z.-M. Lin, and H.-X. Lou. 2012. Steroids from Commiphora mukul display antiproliferative effect against human prostate cancer PC3 cells via induction of apoptosis. Bioorganic & Medicinal Chemistry Letters 22: 4801-4806.
38. Sherr, C.J. 1994. G1 phase progression: Cycling on cue. Cell 79: 551.
39. Sosef, M.; and G. Dauby. 2012. Contribution to the taxonomy of Garcinia (Clusiaceae) in Africa, including two new species from Gabon and a key to the Lower Guinean species. PhytoKeys 17: 41-62.
40. Thoison, O.; D.D. Cuong, A. Gramain, A. Chiaroni, N. Van Hung, and T. Sevenet. 2005. Further rearranged prenylxanthones and benzophenones from Garcinia bracteata. Tetrahedron 61: 8529-8535.
41. Thoison, O.; J. Fahy, V. Dumontet, A. Chiaroni, C. Riche, M. Van Tri, and T. Sevenet. 2000. Cytotoxic prenylxanthones from Garcinia bracteata. Journal of Natural Products 63: 441-446.
42. Thornberry, N.A. 1998. Caspases: Key mediators of apoptosis. Chemistry & Biology 5: 97-103.
43. Wang, J.J.; B.J.S. Sanderson, and W. Zhang. 2011a. Cytotoxic effect of xanthones from pericarp of the tropical fruit mangosteen (Garcinia mangostana Linn.) on human melanoma cells. Food and Chemical Toxicology 49: 2385-2391.
44. Wang, J.J.; Q.H. Shi, W. Zhang, and B.J.S. Sanderson. 2012. Anti-skin cancer properties of phenolic-rich extract from the pericarp of mangosteen (Garcinia mangostana Linn.). Food and Chemical Toxicology 50: 3004-3013.
45. Wang, X.; and W. Chen. 2012. Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis. Anti-Cancer Agents in Medicinal Chemistry 12: 994-1000.
46. Wang, X.; F. Kong, T. Shen, C.Y.F. Young, H. Lou, and H. Yuan. 2011b. Sesquiterpenoids from myrrh inhibit androgen receptor expression and function in human prostate cancer cells. Acta Pharmacologica Sinica 32: 338-344.
47. Waterman, P.G.; and E.G. Crichton. 1980. Xanthones and biflavonoids from Garcinia densivenia stem bark. Phytochemistry 19: 2723-2726.
48. Xiong, Y.; G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
49. Xu, G.; W.L.T. Kan, Y. Zhou, J.Z. Song, Q.B. Han, C.F. Qiao, C.H. Cho, J.A. Rudd, G. Lin, and H.X. Xu. 2010. Cytotoxic acylphloroglucinol derivatives from the twigs of Garcinia cowa. Journal of Natural Products 73: 104-108.
50. Yang, X.; and J. Zhao. 2003. Studies on the chemical constituents from Rabdosia japonica (Burm. f.) Hara var. Glaucocalyx (Maxim.) Hara. Natural Product Research and Development 15: 490-493.
51. Yu, J.; X.-M. Song, G.-Y. Chen, C.-R. Han, J. Zhao, and Q.-W. Yin. 2010. Xanthones from the roots of Calophyllum membranaceum. China Journal of Natural Medicines 8: 433-435.
52. Yuan, H.Q.; F. Kong, X.L. Wang, C.Y.F. Young, X.Y. Hu, and H.X. Lou. 2008. Inhibitory effect of acetyl-11-keto-β-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cells. Biochemical Pharmacology 75: 2112-2121.
53. Zhang, J.; Y. Chen, B. Li, and M. Wang 1997. Chemical constituents of Begonia evansiana Andr. Zhongguo Zhong Yao Za Zhi, 22, 295-296, 320.
54. Zhang, L.J.; C.T. Chiou, J.J. Cheng, H.C. Huang, L.M.Y. Kuo, C.C. Liao, K.F. Bastow, K.H. Lee, and Y.H. Kuo. 2010. Cytotoxic polyisoprenyl benzophenonoids from Garcinia subelliptica. Journal of Natural Products 73: 557-562.